Login / Signup

Use of proton pump inhibitors and the risk of cholangitis: a nationwide cohort study.

Yang Won MinDanbee KangJu-Young ShinMinwoong KangJoo Kyung ParkKwang Hyuck LeeJong Kyun LeeKyu Taek LeePoong-Lyul RheeJae J KimEliseo GuallarJuhee ChoHyuk Lee
Published in: Alimentary pharmacology & therapeutics (2019)
In this large cohort, PPI use was associated with an increased risk of cholangitis. Physicians prescribing PPIs should consider cholangitis as a potential complication of PPI use.
Keyphrases
  • primary care
  • ulcerative colitis
  • protein protein
  • emergency department
  • risk assessment
  • human health
  • climate change